REBLOZYL

Registered
Combined Mark

Key Information

Serial Number

Registration Number

Status

Registered

Ownership

CC

Owner Name

Type: Organization / Corporation

Address

86 Morris Avenue
Summit, NJ 07901

Critical Dates

First Use Date

Nov 8, 2019

Filing Date

Jul 2, 2020

Registration Date

Jan 26, 2021

Mark Descriptions

Goods

Class 5
Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease, cancer

Mark Elements

Text Mark
REBLOZYL
Category
Trademark
Standard Characters
No
Color Claim
No
Drawing/Image Description

The mark consists of "REBLOZYL" with three dots to the right of the word.

Design Search Codes
26.01.15
Circles, exactly three circles
26.01.21
Circles that are totally or partially shaded.
Related Registrations
5321484
6209351
Data source: USPTO TSDR
View on USPTO website

Trademark Timeline

First Use

Nov 8, 2019

Filing Date

Jul 2, 2020

Publication Date

Nov 10, 2020

Registration Date

Jan 26, 2021

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jan 26, 2026

USPTO Records

No documents found for this trademark.

AI Assessment

Never miss important updates for this trademark

Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.